A Single Center, Single-Blind, Randomized, Crossover Pilot Study to Evaluate the Safety and Effects of Anatabloc™, a Dietary Supplement, in Reducing the Urge to Smoke in Daily Smokers Followed by an Open-Label Extension

Rock Creek Pharmaceuticals, Inc.1 site in 1 country109 target enrollmentSeptember 2011

ConditionsTobacco Use Disorder Tobacco Dependence Smoking

Overview

Phase: Phase 1
Intervention: Not specified
Conditions: Tobacco Use Disorder
Sponsor: Rock Creek Pharmaceuticals, Inc.
Enrollment: 109
Locations: 1
Primary Endpoint: effect on subject's craving to smoke
Status: Completed
Last Updated: 10 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This study will consist of 2 phases. Phase 1 will be a one day crossover study to see the effects of study product on a smoker's desire to smoke, measured by changes in scores on questionnaires given over time. Phase 2 will be a two-week extension, in which subjects will self-administer the study product and visit the study site for assessment of desire to smoke and collection of samples for the evaluation of smoking-related biomarkers.

Registry

clinicaltrials.gov

Start Date

September 2011

End Date

December 2011

Last Updated

10 years ago

Study Type

Interventional

Study Design

Crossover